SUPPLY CHAIN RESOURCE COOPERATIVE

  1. The passing of the Obama Healthcare Reform Act, and the subsequent vote by the Supreme Court that the requirement that forces individuals to pay a tax if they do not comply, is perhaps not as surprising as the press would have you believe.  As I’ve noted in prior blogs, “Obamacare is simply a symptom of […]

    [2 comments]

  2. As Yossi Sheffi pointed out at the SCL Europe conference last week, logisics clusters have positive AND negative consequences as well.  One of the biggest negatives is the environmental impact, including poor air, congestion, and health issues.  In Chicago, the cluster results in very long trains – some as long as 2 miles – which can […]

    [No comments]

  3. Yossi Sheffi from MIT’s Sloan School of Management presented at the SCL Europe meeting in Berlin today, and spoke about his upcoming book on logistics clusters.  These comments provide some highlights from his discussion and I met with him to discuss more on these issues. What is a cluster?  A cluster in its simplest form […]

    [2 comments]

  4. I sat in on a panel debate today at the World Trade Group meeting for Supply Chain and Logistics Europe in Berlin.  During the panel, I had an opportunity to speak with Clemens Woerhle, Head of Beiersdorf’s global end to end supply chain operations, including manufacturing, logistics procurement, and S&OP. Most of you have probably […]

    [3 comments]

  5. Had coffee with my friend Gerard Chick while in London this week, who is on the research team at CIPS (the Chartered Institute of Professional Supply Management).  Gerard and I have done a good bit of work in the past, in particular holding an executive summit with British CPO’s, on the status of the supply […]

    [No comments]

  6. My new book comes out this month, which focuses on the biopharma supply chain and the numerous trends and challenges that exist today, and which will continue to occur down the road.. Titled “Distribution, Regulatory, Systems, and Structural Changes in Biopharmaceutical Supply Chain”, the book covers the major themes and changes in the biopharmaceutical supply […]

    [No comments]